BroadOak partnered with United BioChannels (UBC) to acquire ORFLO Technologies (ORFLO) in October 2022. ORFLO, a leading manufacturer of cell counting and characterization technologies, will be led by Varshal Davé, UBC’s Managing Partner, who will assume the role of Chief Executive Officer. With over 3,000 instruments installed worldwide, ORFLO has a strong market presence and an established customer base that the company can build under UBC’s leadership.
The full press release is below.
SAN DIEGO, Oct. 27, 2022 /PRNewswire/ — United BioChannels (UBC), a commercial strategy consultancy, announced its acquisition of ORFLO Technologies, LLC, from Gemini Bioproducts. The acquisition represents an opportunity for both ORFLO and UBC to collaboratively increase the commercial presence of ORFLO and build market share using UBC’s Modular Method of developing commercial strategy and tactical execution. ORFLO, a leading manufacturer of cell counting and characterization technologies, will be led by Varshal Davé, UBC’s Managing Partner, who will assume the role of Chief Executive Officer. The acquisition is funded through a collaboration between UBC and BroadOak Capital Partners.
“We are very excited to bring ORFLO Technologies into the United BioChannels family,” said UBC’s President Jeff Whitmore. “ORFLO has historically lacked a strong commercial focus, so our expertise presents an opportunity for a synergistic relationship. We believe that our processes will lead to increased visibility and revenue for ORFLO.”
“We have been tracking the progress of ORFLO Technologies for quite some time,” added Bill Snider, Partner at BroadOak Capital Partners, “and we see some great potential that the UBC team can unlock. ORFLO has a strong market presence and we think UBC’s leadership can only help the company grow.”
Cell and gene therapy, amongst other bioprocessing applications, require robust instrumentation as integral components of their workflow. Cell counters in particular serve critical quality control functions in multiple stages of these complex processes. Ketchum, Idaho, based ORFLO Technologies has excelled in these processes, having been implemented as standard instruments in regulated workflows for many leading bioprocessing companies. With a strong market presence having over 3,000 instruments installed worldwide, ORFLO has an established customer base that the company can build upon under UBC’s leadership.